Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Shares Outstanding (2016 - 2025)

AtriCure (ATRC) has disclosed Shares Outstanding for 16 consecutive years, with $49.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.89% to $49.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.8 million, a 1.89% increase, with the full-year FY2025 number at $49.8 million, up 1.89% from a year prior.
  • Shares Outstanding was $49.8 million for Q4 2025 at AtriCure, roughly flat from $49.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.8 million in Q4 2025 to a low of $45.6 million in Q1 2021.
  • A 5-year average of $47.6 million and a median of $47.4 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: increased 13.84% in 2021, then rose 1.11% in 2022.
  • AtriCure's Shares Outstanding stood at $46.0 million in 2021, then increased by 1.19% to $46.6 million in 2022, then grew by 2.07% to $47.5 million in 2023, then increased by 2.83% to $48.9 million in 2024, then rose by 1.89% to $49.8 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Shares Outstanding are $49.8 million (Q4 2025), $49.7 million (Q3 2025), and $49.7 million (Q2 2025).